• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立南北镰状细胞病研究伙伴关系的理由。

A case for developing North-South partnerships for research in sickle cell disease.

作者信息

Weatherall David, Hofman Karen, Rodgers Griffin, Ruffin John, Hrynkow Sharon

机构信息

Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom.

出版信息

Blood. 2005 Feb 1;105(3):921-3. doi: 10.1182/blood-2004-06-2404. Epub 2004 Oct 5.

DOI:10.1182/blood-2004-06-2404
PMID:15466925
Abstract

For a better understanding of the pathophysiology and mechanisms of phenotypic diversity of sickle cell disease, and for the improvement of its management globally, there is a strong case for developing sustainable research partnerships between rich and poor countries.

摘要

为了更好地理解镰状细胞病的病理生理学和表型多样性机制,并在全球范围内改善其治疗,富国和穷国之间建立可持续的研究伙伴关系很有必要。

相似文献

1
A case for developing North-South partnerships for research in sickle cell disease.建立南北镰状细胞病研究伙伴关系的理由。
Blood. 2005 Feb 1;105(3):921-3. doi: 10.1182/blood-2004-06-2404. Epub 2004 Oct 5.
2
New advances in the pathophysiology and management of sickle cell disease.镰状细胞病的病理生理学与治疗新进展
Curr Opin Hematol. 1994 Mar;1(2):125-35.
3
A global perspective on sickle cell disease.全球视角下的镰状细胞病。
Pediatr Blood Cancer. 2012 Aug;59(2):386-90. doi: 10.1002/pbc.24175. Epub 2012 Apr 25.
4
[The Research Center and the Fight Against Sickle Cell Anemia of Bamako: an example of a North-South public private partnership].[巴马科镰状细胞贫血研究中心与抗击行动:南北公私伙伴关系的一个范例]
Bull Acad Natl Med. 2013 Jun;197(6):1221-3.
5
Sickle cell anemia: pathophysiology, management, and prospects for the future.镰状细胞贫血:病理生理学、管理及未来展望。
J Clin Apher. 1991;6(4):221-3. doi: 10.1002/jca.2920060410.
6
Pathophysiology and perioperative management of sickle cell disease.镰状细胞病的病理生理学与围手术期管理
J Perioper Pract. 2015 Jun;25(6):101-4. doi: 10.1177/175045891502500602.
7
Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.制定全球镰状细胞病议程:贝宁共和国科托努国际研讨会和讲习班报告。
Am J Prev Med. 2010 Apr;38(4 Suppl):S571-5. doi: 10.1016/j.amepre.2009.12.021.
8
Sickle cell disease: Reducing the global disease burden.镰状细胞病:降低全球疾病负担。
Int J Lab Hematol. 2019 May;41 Suppl 1:82-88. doi: 10.1111/ijlh.13023.
9
Review/overview of pain in sickle cell disease.镰状细胞病疼痛的综述/概述。
Complement Ther Med. 2020 Mar;49:102327. doi: 10.1016/j.ctim.2020.102327. Epub 2020 Feb 3.
10
Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations.镰状细胞病:通过国际研究合作将临床护理转化到资源匮乏国家。
Semin Hematol. 2018 Apr;55(2):102-112. doi: 10.1053/j.seminhematol.2018.04.010. Epub 2018 Apr 26.

引用本文的文献

1
Primary Stroke Screening and Hydroxyurea Treatment for Sickle Cell Anemia in Pediatric Healthcare Settings in East and Central Africa: A Narrative Review of Capacity Gaps and Opportunities.东非和中非儿科医疗环境中镰状细胞贫血的初级卒中筛查与羟基脲治疗:能力差距与机遇的叙述性综述
Public Health Rev. 2025 May 15;46:1608359. doi: 10.3389/phrs.2025.1608359. eCollection 2025.
2
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial.西班牙裔镰状细胞贫血儿童的中风预防:SACRED试验
Blood Adv. 2025 Apr 22;9(8):1791-1800. doi: 10.1182/bloodadvances.2024014327.
3
Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia.
GATA1水平降低与镰状细胞贫血中无效的红细胞生成有关。
Haematologica. 2025 May 1;110(5):1150-1163. doi: 10.3324/haematol.2024.286010. Epub 2024 Dec 5.
4
Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in Italy.意大利治疗依赖输血的β地中海贫血和镰状细胞病伴复发性血管闭塞性危象的死亡率、临床并发症及医疗资源利用情况
Pharmacoecon Open. 2025 Jan;9(1):115-124. doi: 10.1007/s41669-024-00532-4. Epub 2024 Oct 28.
5
A Multidisciplinary Educational Approach for Children With Chronic Illness: An Intervention Case Study.针对慢性病患儿的多学科教育方法:一项干预案例研究。
Contin Educ. 2020 Jan 9;1(1):8-21. doi: 10.5334/cie.2. eCollection 2020.
6
Prevalence of sickle cell trait and needs assessment for uptake of sickle cell screening among secondary school students in Kampala City, Uganda.乌干达坎帕拉市中学生镰状细胞特征的流行情况及镰状细胞筛查参与度评估。
PLoS One. 2024 Jan 19;19(1):e0296119. doi: 10.1371/journal.pone.0296119. eCollection 2024.
7
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.双氢青蒿素-哌喹或磺胺多辛-乙胺嘧啶预防非洲东部和南部镰状细胞贫血儿童疟疾(CHEMCHA):一项多中心、两臂、双盲、随机、安慰剂对照优效性试验的方案。
Trials. 2023 Apr 5;24(1):257. doi: 10.1186/s13063-023-07274-4.
8
Clinical and laboratory characterization of adult sickle cell anemia patients in Kinshasa.金沙萨成年镰状细胞贫血患者的临床和实验室特征。
PLoS One. 2022 Dec 16;17(12):e0278478. doi: 10.1371/journal.pone.0278478. eCollection 2022.
9
Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening.西非几内亚比绍多民族人群中血红蛋白S等位基因和单倍型的分布:对公共卫生筛查的启示
Front Pediatr. 2022 Apr 7;10:826262. doi: 10.3389/fped.2022.826262. eCollection 2022.
10
Parvovirus Infection and Thrombotic Thrombocytopenic Purpura in an Adult Patient With Sickle Cell Beta-Thalassemia.一名镰状细胞β地中海贫血成年患者的细小病毒感染与血栓性血小板减少性紫癜
Cureus. 2021 Jul 4;13(7):e16173. doi: 10.7759/cureus.16173. eCollection 2021 Jul.